181 related articles for article (PubMed ID: 18019850)
1. Symptom clusters in patients with newly-diagnosed brain tumors.
Gleason JF; Case D; Rapp SR; Ip E; Naughton M; Butler JM; McMullen K; Stieber V; Saconn P; Shaw EG
J Support Oncol; 2007 Oct; 5(9):427-33, 436. PubMed ID: 18019850
[TBL] [Abstract][Full Text] [Related]
2. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
[TBL] [Abstract][Full Text] [Related]
3. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
[TBL] [Abstract][Full Text] [Related]
4. Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
Delbari A; Salman-Roghani R; Lokk J
Eur Neurol; 2011; 66(1):7-13. PubMed ID: 21701174
[TBL] [Abstract][Full Text] [Related]
5. Increasing stringency in symptom cluster research: a methodological exploration of symptom clusters in patients with inoperable lung cancer.
Henoch I; Ploner A; Tishelman C
Oncol Nurs Forum; 2009 Nov; 36(6):E282-92. PubMed ID: 19887341
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
7. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
[TBL] [Abstract][Full Text] [Related]
8. Symptom clusters in cancer patients with brain metastases.
Chow E; Fan G; Hadi S; Wong J; Kirou-Mauro A; Filipczak L
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):76-82. PubMed ID: 17981447
[TBL] [Abstract][Full Text] [Related]
9. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
Mendonça DA; Menezes K; Jog MS
Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
[TBL] [Abstract][Full Text] [Related]
11. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
[TBL] [Abstract][Full Text] [Related]
12. Symptom clusters and quality of life in Korean patients with hepatocellular carcinoma.
Ryu E; Kim K; Cho MS; Kwon IG; Kim HS; Fu MR
Cancer Nurs; 2010; 33(1):3-10. PubMed ID: 19926981
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.
Pae CU; Marks DM; Masand PS; Peindl K; Hooper-Wood C; Han C; Mannelli P; Ciccone P; Patkar AA
Clin Neuropharmacol; 2009; 32(2):85-8. PubMed ID: 19512961
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
[TBL] [Abstract][Full Text] [Related]
15. [Methylphenidate in palliative care in cancer patient: a double-blind randomised trial versus placebo].
Laval G; Paris A
Bull Cancer; 2008 Feb; 95(2):241-6. PubMed ID: 18304907
[TBL] [Abstract][Full Text] [Related]
16. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study.
So WK; Marsh G; Ling WM; Leung FY; Lo JC; Yeung M; Li GK
Oncol Nurs Forum; 2009 Jul; 36(4):E205-14. PubMed ID: 19581224
[TBL] [Abstract][Full Text] [Related]
17. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
18. Symptom cluster patterns during the first year after diagnosis with cancer.
Molassiotis A; Wengström Y; Kearney N
J Pain Symptom Manage; 2010 May; 39(5):847-58. PubMed ID: 20226621
[TBL] [Abstract][Full Text] [Related]
19. [Changes in QOL in patients with brain tumors measured by mood changes during and after treatment].
Suzuki R; Hirao M; Miyo T; Nagashima G; Fujimoto T; Ooshima A; Higuchi T
No Shinkei Geka; 1998 Sep; 26(9):795-801. PubMed ID: 9757456
[TBL] [Abstract][Full Text] [Related]
20. Use of methylphenidate in traumatic brain injury.
Siddall OM
Ann Pharmacother; 2005; 39(7-8):1309-13. PubMed ID: 15914519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
